Ionis Pharmaceuticals

Switzerlandcompany5.0Global Dominance: 0.00%

Ionis Pharmaceuticals is a biopharmaceutical company known for its pioneering work in RNA-targeted drug discovery and development. The company specializes in designing and developing therapies for a variety of diseases, including genetic disorders, cancers, and cardiovascular diseases. In recent news, Ionis Pharmaceuticals was mentioned in the context of Novartis' recent setbacks in drug development, particularly regarding a collaboration on a cardiovascular drug that did not meet its efficacy targets in clinical trials.